(PDF) Treatment of the Ppt1–/– Mouse Model of Infantile

Treatment of the Ppt1–/– Mouse Model of Infantile Neuronal Ceroid Lipofuscinosis With the N-Methyl-D-Aspartate (NMDA) Receptor Antagonist Memantine

Journal of Child Neurology - United States

doi 10.1177/0883073813494480

Full Text

Abstract

Available in full text

Categories

Date

September 1, 2013

Authors

Attila D. Kovács

David A. Pearce

Publisher

SAGE Publications

Related search

Infantile Neuronal Ceroid Lipofuscinosis

English

The Uncompetitive N-Methyl-D-Aspartate (NMDA) Receptor Antagonist Memantine Prolongs Spatial Memory in a Rat Delayed Radial-Arm Maze Memory Task

European Journal of Pharmacology

English

Ovine Neuronal Ceroid Lipofuscinosis: A Large Animal Model Syntenic With the Human Neuronal Ceroid Lipofuscinosis Variant CLN6.

Journal of Medical Genetics

English

Inducible Transgenic Expression of Tripeptidyl Peptidase 1 in a Mouse Model of Late-Infantile Neuronal Ceroid Lipofuscinosis

Multidisciplinary

English

Pupillary Light Reflex Deficits in a Canine Model of Late Infantile Neuronal Ceroid Lipofuscinosis

Experimental Eye Research

Molecular Neuroscience

Sensory Systems

English

197. AAV2/5-Mediated Gene Therapy Synergizes With Bone Marrow Transplantation in the Treatment of Infantile Neuronal Ceroid Lipofuscinosis

Molecular Therapy

Molecular Medicine

Molecular Biology

English

N-Methyl D-Aspartate Receptor Antagonist Kynurenic Acid Affects Human Cortical Development

Frontiers in Neuroscience

English

Native and Complexed IGF-1: Biodistribution and Pharmacokinetics in Infantile Neuronal Ceroid Lipofuscinosis

Journal of Drug Delivery

English

Activation of the Genetically Defined M1 Muscarinic Receptor Potentiates N-Methyl-D-Aspartate (NMDA) Receptor Currents in Hippocampal Pyramidal Cells

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English